eli lily glp-1 Lilly launches pill, kicking off showdown with Novo Nordisk FDA approves Eli Lilly's new

& Kirkwood, T

And because theyre not biosimilar but just acknowledging that

Therapeutics and clinical expansion of GLP-1 analogues is presenting several market opportunities

The pharmacology of drugs such as Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual incretin receptor agonists is mainly characterized by two mechanisms of action

How GLP-1 agonists drive weight loss Appetite control GLP-1s mimic hormones that signal fullness to the brain, reducing hunger and curbing cravings Slower digestion GLP-1 agonists slow gastric emptying, helping patients feel fuller longer, and preventing overeating Improved insulin sensitivity Originally developed for diabetes care, GLP-1 medications improve how the body processes insulin Sustainable weight loss Through reduced appetite and better metabolism, patients achieve steady, meaningful weight loss Long-term benefits GLP-1 agonists not only aid weight loss but can also improve heart health and reduce diabetes risk How GLP-1 agonists drive weight loss Ongoing shortages of popular GLP-1 medications like Ozempic and Mounjaro have left many patients without the treatment they need, interrupting their progress just when consistency matters most

Any decision to continue, adjust, or stop medication should be made with your healthcare provider.